PhoenixBio
Biotechnology Research
Hiroshima, Hirosima, Jp
24 employees
- Employees
- 24
- Contacts
- 3
- Emails
- 3
PhoenixBio Overview
- Headquarters
- Hiroshima, Hirosima, Jp
- Website
- phoenixbio.co.jp
- Industry
- Biotechnology Research
- Employees
- 24
- Founded
- 2002
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About PhoenixBio
PhoenixBio established its proprietary chimeric mouse model, the PXB-mouse®, with a highly humanized liver through years of research and development. With the addition of fresh, isolated human hepatocytes, PXB-cells®, the applications of our products and study services are as wide-ranging as our clients’ research goals. The PXB-mouse animal background (cDNA-uPA/SCID) makes for a robust, consistent model that maintains up to 95% stable human hepatocyte engraftment. The reconstituted humanized liver features structural and biological characteristics commonly observed in normal human livers. The model has proven to be a world-wide gold standard for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) research, but usage is expanding in the fields of: . Drug Metabolism and Pharmacokinetics, · Human Specific Hepatotoxicity, · Oligonucleotide and Gene-based Therapeutics, · HBV & HBV/HDV, · NASH/NAFLD, · Other human liver-related research fields. PXB-cells® are approximately 95% pure human hepatocytes freshly isolated from the PXB-mouse®. They feature long-term stability of up to 40 days, and allow for consistent supply from the same donor. One unique feature of PXB-cells® and PXB-mice is the ability to directly compare in vitro and in vitro data from the same human donor. With over 300 scientific publications to its credit, the PXB-mouse is the world’s most widely used chimeric mouse model with a humanized liver. A high replacement index, lifespan of up to 2 years, and no secondary drug to maintain mouse liver injury means that your data can translate better to humans than ever before. Please visit our website at https://www.phoenixbio.com/ to learn more about our model and inquire about our offered products and services.
PhoenixBio Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
PhoenixBio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Yoshinari Miyata | Chief Innovation Officer at Phoenixbio Usa | Ann Arbor, Michigan, United States |
Email
|
| Chise Mukaidani | Phoenixbio Co., Ltd. - Executive Director, Research and Development Department | Hiroshima, Japan |
View
|
| Takashi Shimada | President and CEO at Phoenixbio Co., Ltd | Hiroshima, Japan |
Email
|
| Li Na, Phd, Qihc (Cm) | Phd Scientist - Expert in Biological Assays & Preclinical Research - Supporting Biotech Innovation | Raleigh-durham-chapel Hill Area, United States |
Email
|
Employees by Management Level
Executive
3 profiles
Individual contributor
3 profiles
Director
2 profiles
Manager
2 profiles
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 3 | 3 | 1 |
Compare Similar Companies to PhoenixBio
Recursion
Biotechnology Research
BTIG
Financial Services
Orbital Therapeutics
Biotechnology Research
Research Diets, Inc.
Research Services
Yecuris Corporation
Biotechnology Research
KMT Hepatech, Inc. - PhoenixBio Group
Biotechnology
Fenfyre
Marketing Services
Glyco Biologics Inc.
Pharmaceutical Manufacturing
Molscreen
Biotechnology Research
OneSoftware Powered By FlexSchema
Desktop Computing Software Products